Stroke - Pipeline Review, H1 2020

  • Life Sciences
  • 30 April 2020
  • 716 Pages
  • Formats:    
  • Report Code: 24WT-3603

Stroke Pipeline Review H1 - Overview

Stroke - Pipeline Review, H1 2020

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H1 2020, provides an overview of the Stroke (Cardiovascular) pipeline landscape.

Stroke is a condition in which the brain cells suddenly die because of a lack of oxygen. Symptoms occur rapidly and usually last a short time, from a few minutes to a couple of hours. The symptoms of a stroke usually appear suddenly. Initially the person may feel sick, and look pale and very unwell. They may complain of a sudden headache. They may have sudden numbness in their face or limbs, particularly down one side of their body. They may appear confused and have trouble talking or understanding what is being said to them. They may have vision problems, and trouble walking or keeping their balance.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Stroke - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Stroke (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 14, 38, 23, 1, 2, 132, 17 and 2 respectively. Similarly, the Universities portfolio in Phase III, Preclinical and Discovery stages comprises 1, 33 and 5 molecules, respectively.

Stroke (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Stroke (Cardiovascular).
- The pipeline guide reviews pipeline therapeutics for Stroke (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Stroke (Cardiovascular) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Stroke (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Stroke (Cardiovascular)

Reasons to Buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Stroke (Cardiovascular).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Stroke (Cardiovascular) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents
Introduction
Stroke - Overview
Stroke - Therapeutics Development
Stroke - Therapeutics Assessment
Stroke - Companies Involved in Therapeutics Development
Stroke - Drug Profiles
Stroke - Dormant Projects
Stroke - Discontinued Products
Stroke - Product Development Milestones
Appendix
List of Tables

Number of Products under Development for Stroke, H1 2020

Number of Products under Development by Companies, H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..2), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..3), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..4), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..5), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..6), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..7), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..8), H1 2020

Number of Products under Development by Companies, H1 2020 (Contd..9), H1 2020

Number of Products under Development by Universities/Institutes, H1 2020

Number of Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020

Products under Development by Companies, H1 2020

Products under Development by Companies, H1 2020 (Contd..1), H1 2020

Products under Development by Companies, H1 2020 (Contd..2), H1 2020

Products under Development by Companies, H1 2020 (Contd..3), H1 2020

Products under Development by Companies, H1 2020 (Contd..4), H1 2020

Products under Development by Companies, H1 2020 (Contd..5), H1 2020

Products under Development by Companies, H1 2020 (Contd..6), H1 2020

Products under Development by Companies, H1 2020 (Contd..7), H1 2020

Products under Development by Companies, H1 2020 (Contd..8), H1 2020

Products under Development by Companies, H1 2020 (Contd..9), H1 2020

Products under Development by Companies, H1 2020 (Contd..10), H1 2020

Products under Development by Companies, H1 2020 (Contd..11), H1 2020

Products under Development by Companies, H1 2020 (Contd..12), H1 2020

Products under Development by Universities/Institutes, H1 2020

Products under Development by Universities/Institutes, H1 2020 (Contd..1), H1 2020

Number of Products by Stage and Target, H1 2020

Number of Products by Stage and Target, H1 2020 (Contd..1), H1 2020

Number of Products by Stage and Target, H1 2020 (Contd..2), H1 2020

Number of Products by Stage and Target, H1 2020 (Contd..3), H1 2020

Number of Products by Stage and Target, H1 2020 (Contd..4), H1 2020

Number of Products by Stage and Target, H1 2020 (Contd..5), H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..1), H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..2), H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..3), H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..4), H1 2020

Number of Products by Stage and Mechanism of Action, H1 2020 (Contd..5), H1 2020

Number of Products by Stage and Route of Administration, H1 2020

Number of Products by Stage and Molecule Type, H1 2020

Stroke - Pipeline by AbbVie Inc, H1 2020

Stroke - Pipeline by Acorda Therapeutics Inc, H1 2020

Stroke - Pipeline by Acticor Biotech SAS, H1 2020

Stroke - Pipeline by advanceCor GmbH, H1 2020

Stroke - Pipeline by Advanced BioMatrix Inc, H1 2020

Stroke - Pipeline by AegisCN LLC, H1 2020

Stroke - Pipeline by Aegle Therapeutics Corp, H1 2020

Stroke - Pipeline by Affibody AB, H1 2020

Stroke - Pipeline by Allife Medical Science and Technology Co Ltd, H1 2020

Stroke - Pipeline by Allosteros Therapeutics Inc, H1 2020

Stroke - Pipeline by Anavex Life Sciences Corp, H1 2020

Stroke - Pipeline by Ankasa Regenerative Therapeutics Inc, H1 2020

Stroke - Pipeline by Annovis Bio Inc, H1 2020

Stroke - Pipeline by Anthos Therapeutics Inc, H1 2020

Stroke - Pipeline by AntiRadical Therapeutics LLC, H1 2020

Stroke - Pipeline by Antoxis Ltd, H1 2020

Stroke - Pipeline by Apellis Pharmaceuticals Inc, H1 2020

Stroke - Pipeline by Aposcience AG, H1 2020

Stroke - Pipeline by APT Therapeutics Inc, H1 2020

Stroke - Pipeline by AptaTargets SL, H1 2020

Stroke - Pipeline by AriBio, H1 2020

Stroke - Pipeline by ArmaGen Inc, H1 2020

Stroke - Pipeline by Aronora Inc, H1 2020

Stroke - Pipeline by Artelo Biosciences Inc, H1 2020

Stroke - Pipeline by ArunA Biomedical Inc, H1 2020

Stroke - Pipeline by Asta Pharmaceuticals Co Ltd, H1 2020

Stroke - Pipeline by AstraZeneca Plc, H1 2020

Stroke - Pipeline by Athersys Inc, H1 2020

Stroke - Pipeline by Aurum Biosciences Ltd, H1 2020

Stroke - Pipeline by Australia Medical Industries Pty Ltd, H1 2020

Stroke - Pipeline by Avilex Pharma ApS, H1 2020

Stroke - Pipeline by Axolo Pharma Inc, H1 2020

Stroke - Pipeline by Band Therapeutics LLC, H1 2020

Stroke - Pipeline by Bayer AG, H1 2020

Stroke - Pipeline by Baylx Inc, H1 2020

Stroke - Pipeline by Beijing Yinfeng Dingcheng Bioengineering Co Ltd, H1 2020

Stroke - Pipeline by Bilix Co Ltd, H1 2020

Stroke - Pipeline by BioAxone BioSciences Inc, H1 2020

Stroke - Pipeline by Biogen Inc, H1 2020

Stroke - Pipeline by Boehringer Ingelheim International GmbH, H1 2020

Stroke - Pipeline by Brain-Gen LLC, H1 2020

Stroke - Pipeline by Bristol-Myers Squibb Co, H1 2020

Stroke - Pipeline by CardioVascular BioTherapeutics Inc, H1 2020

Stroke - Pipeline by Celltrion Inc, H1 2020

Stroke - Pipeline by Cenyx Biotech Inc, H1 2020

Stroke - Pipeline by Cerebrum Therapeutics Inc, H1 2020

Stroke - Pipeline by CHA Biotech Co Ltd, H1 2020

Stroke - Pipeline by China Resources Emde Biological Pharmaceutical Co Ltd, H1 2020

Stroke - Pipeline by Cogentis Therapeutics Inc, H1 2020

Stroke - Pipeline by CohBar Inc, H1 2020

Stroke - Pipeline by Constant Therapeutics LLC, H1 2020

Stroke - Pipeline by Creative Medical Technology Holdings Inc, H1 2020

Stroke - Pipeline by Crioestaminal Saude e Tecnologia SA, H1 2020

Stroke - Pipeline by CSPC Pharmaceutical Group Ltd, H1 2020

Stroke - Pipeline by Curacle Co Ltd, H1 2020

Stroke - Pipeline by CuroNZ Ltd, H1 2020

Stroke - Pipeline by Daewoong Pharmaceutical Co Ltd, H1 2020

Stroke - Pipeline by Daiichi Sankyo Co Ltd, H1 2020

Stroke - Pipeline by DeckTherapeutics Inc, H1 2020

Stroke - Pipeline by Deha Pharmaceutical LLC, H1 2020

Stroke - Pipeline by DiaMedica Therapeutics Inc, H1 2020

Stroke - Pipeline by Diffusion Pharmaceuticals Inc, H1 2020

Stroke - Pipeline by Edvince AB, H1 2020

Stroke - Pipeline by EIP Pharma LLC, H1 2020

Stroke - Pipeline by Emerald Organic Products Inc, H1 2020

Stroke - Pipeline by Epigen Biosciences Inc, H1 2020

Stroke - Pipeline by Epygen Biotech Pvt Ltd, H1 2020

Stroke - Pipeline by Ever Supreme Bio Technology Co Ltd, H1 2020

Stroke - Pipeline by Evgen Pharma Plc, H1 2020

Stroke - Pipeline by eXithera Pharmaceuticals Inc, H1 2020

Stroke - Pipeline by Exscien Corp, H1 2020

Stroke - Pipeline by F. Hoffmann-La Roche Ltd, H1 2020

Stroke - Pipeline by Fortuna Fix Inc, H1 2020

Stroke - Pipeline by Freeox Biotech SL, H1 2020

Stroke - Pipeline by FUJIFILM Toyama Chemical Co Ltd, H1 2020

Stroke - Pipeline by GABA Therapeutics Inc, H1 2020

Stroke - Pipeline by Genentech Inc, H1 2020

Stroke - Pipeline by Genervon Biopharmaceuticals LLC, H1 2020

Stroke - Pipeline by Glucox Biotech AB, H1 2020

Stroke - Pipeline by GNT Pharma Co Ltd, H1 2020

Stroke - Pipeline by Guangzhou Cellprotek Pharmaceutical Co Ltd, H1 2020

Stroke - Pipeline by Guangzhou Magpie Pharmaceutical Co Ltd, H1 2020

Stroke - Pipeline by Guangzhou Recomgen Biotech Co Ltd, H1 2020

Stroke - Pipeline by Guangzhou-Sheng Jian Chi Pharmaceutical Co Ltd, H1 2020

Stroke - Pipeline by Gwoxi Stem Cell Applied Technology Co Ltd, H1 2020

Stroke - Pipeline by Hefei Industrial Pharmaceutical Institute Co Ltd, H1 2020

Stroke - Pipeline by Hefei Medical & Pharmaceutical Co Ltd, H1 2020

Stroke - Pipeline by Hemostemix Inc, H1 2020

Stroke - Pipeline by Hibernaid Inc, H1 2020

Stroke - Pipeline by Hillhurst Biopharmaceuticals Inc, H1 2020

Stroke - Pipeline by Hope Biosciences LLC, H1 2020

Stroke - Pipeline by HSRx Group, H1 2020

Stroke - Pipeline by Immunwork Inc, H1 2020

Stroke - Pipeline by Instituto Biomar SA, H1 2020

Stroke - Pipeline by International Stem Cell Corp, H1 2020

Stroke - Pipeline by JCR Pharmaceuticals Co Ltd, H1 2020

Stroke - Pipeline by Jeil Pharmaceutical Co Ltd, H1 2020

Stroke - Pipeline by Jiangsu Ouwei Pharmaceutical Co Ltd, H1 2020

Stroke - Pipeline by JT Pharmaceuticals Inc, H1 2020

Stroke - Pipeline by Kai Nuo Bio Sci Co Ltd, H1 2020

Stroke - Pipeline by Kyoto Drug Discovery & Development Co Ltd, H1 2020

Stroke - Pipeline by Les Laboratoires Servier SAS, H1 2020

Stroke - Pipeline by Living Cell Technologies Ltd, H1 2020

Stroke - Pipeline by Lixte Biotechnology Holdings Inc, H1 2020

Stroke - Pipeline by LTT Bio-Pharma Co Ltd, H1 2020

Stroke - Pipeline by Lumosa Therapeutics Co Ltd, H1 2020

Stroke - Pipeline by M et P Pharma AG, H1 2020

Stroke - Pipeline by Mapreg SAS, H1 2020

Stroke - Pipeline by Marizyme Inc, H1 2020

Stroke - Pipeline by Meridigen Biotech Co Ltd, H1 2020

Stroke - Pipeline by MetiMedi Pharmaceuticals Co Ltd, H1 2020

Stroke - Pipeline by Mitoconix Bio Ltd, H1 2020

Stroke - Pipeline by Modulation Therapeutics Inc, H1 2020

Stroke - Pipeline by NC Medical Research Inc, H1 2020

Stroke - Pipeline by NeuExcell Therapeutics Inc, H1 2020

Stroke - Pipeline by Neuraly Inc, H1 2020

Stroke - Pipeline by Neuren Pharmaceuticals Ltd, H1 2020

Stroke - Pipeline by NeurExo Sciences LLC, H1 2020

Stroke - Pipeline by Neurodon LLC, H1 2020

Stroke - Pipeline by NeuroFix Therapeutics LLC, H1 2020

Stroke - Pipeline by NeuroNascent Inc, H1 2020

Stroke - Pipeline by NeurOp Inc, H1 2020

Stroke - Pipeline by NeuroTrauma Sciences LLC, H1 2020

Stroke - Pipeline by Neurotrope Bioscience Inc, H1 2020

Stroke - Pipeline by New World Laboratories Inc, H1 2020

Stroke - Pipeline by Nipro Corp, H1 2020

Stroke - Pipeline by NoNO Inc, H1 2020

Stroke - Pipeline by Novago Therapeutics AG, H1 2020

Stroke - Pipeline by Novartis AG, H1 2020

Stroke - Pipeline by NuvOx Pharma LLC, H1 2020

Stroke - Pipeline by Nyrada Inc, H1 2020

Stroke - Pipeline by Omniox Inc, H1 2020

Stroke - Pipeline by OTR3 SAS, H1 2020

Stroke - Pipeline by Paracelsus Neuroscience I LLC, H1 2020

Stroke - Pipeline by Park Active Molecules, H1 2020

Stroke - Pipeline by Pharmagenesis Inc, H1 2020

Stroke - Pipeline by PharmatrophiX Inc, H1 2020

Stroke - Pipeline by Pharmazz Inc, H1 2020

Stroke - Pipeline by Pharmicell Co Ltd, H1 2020

Stroke - Pipeline by Phoenix Biotechnology Inc, H1 2020

Stroke - Pipeline by PhytoHealth Corp, H1 2020

Stroke - Pipeline by Prediction BioSciences SAS, H1 2020

Stroke - Pipeline by Primary Peptides Inc, H1 2020

Stroke - Pipeline by Protheragen Inc, H1 2020

Stroke - Pipeline by Q Therapeutics Inc, H1 2020

Stroke - Pipeline by Regenera Pharma Ltd, H1 2020

Stroke - Pipeline by Regeneron Pharmaceuticals Inc, H1 2020

Stroke - Pipeline by RegeneRx Biopharmaceuticals Inc, H1 2020

Stroke - Pipeline by ReNetX Bio, H1 2020

Stroke - Pipeline by ReNeuron Group Plc, H1 2020

Stroke - Pipeline by Rich Pharmaceuticals Inc, H1 2020

Stroke - Pipeline by Rubicon Biotechnology Inc, H1 2020

Stroke - Pipeline by Saje Pharma LLC, H1 2020

Stroke - Pipeline by SanBio Inc, H1 2020

Stroke - Pipeline by Saneron CCEL Therapeutics Inc, H1 2020

Stroke - Pipeline by Saniona AB, H1 2020

Stroke - Pipeline by Sansho Co Ltd, H1 2020

Stroke - Pipeline by Savara Inc, H1 2020

Stroke - Pipeline by Seneca Biopharma Inc, H1 2020

Stroke - Pipeline by Sentan Pharma Inc, H1 2020

Stroke - Pipeline by Shanghai Angecon Biotechnology Corp, H1 2020

Stroke - Pipeline by Shanghai SIMR Biotech Co Ltd, H1 2020

Stroke - Pipeline by Shanghai Zhimeng Biopharma Inc, H1 2020

Stroke - Pipeline by Shin Poong Pharm Co Ltd, H1 2020

Stroke - Pipeline by Shionogi & Co Ltd, H1 2020

Stroke - Pipeline by Simcere Pharmaceutical Group, H1 2020

Stroke - Pipeline by Stemedica Cell Technologies Inc, H1 2020

Stroke - Pipeline by Stemetix Inc, H1 2020

Stroke - Pipeline by Stream Biomedical Inc, H1 2020

Stroke - Pipeline by SunBio Inc, H1 2020

Stroke - Pipeline by Suzhou Pharmavan Cancer Research Center Co Ltd, H1 2020

Stroke - Pipeline by Suzhou Ribo Life Sciences Co Ltd, H1 2020

Stroke - Pipeline by TaiGen Biotechnology Co Ltd, H1 2020

Stroke - Pipeline by Tasly Pharmaceutical Group Co Ltd, H1 2020

Stroke - Pipeline by Techfields Pharma Co Ltd, H1 2020

Stroke - Pipeline by The Cell Factory BVBA, H1 2020

Stroke - Pipeline by TheraSource LLC, H1 2020

Stroke - Pipeline by Theratome Bio Inc, H1 2020

Stroke - Pipeline by Thrombolytic Science International LLC, H1 2020

Stroke - Pipeline by TikoMed AB, H1 2020

Stroke - Pipeline by TMS Co Ltd, H1 2020

Stroke - Pipeline by Translational Sciences Inc, H1 2020

Stroke - Pipeline by Valin Technologies Ltd, H1 2020

Stroke - Pipeline by Vanworld Pharmaceutical (Rugao) Company Ltd, H1 2020

Stroke - Pipeline by Vect-Horus SAS, H1 2020

Stroke - Pipeline by Verseon Corp, H1 2020

Stroke - Pipeline by Virogenomics BioDevelopment Inc, H1 2020

Stroke - Pipeline by Virtici LLC, H1 2020

Stroke - Pipeline by Xcelthera INC, H1 2020

Stroke - Pipeline by Xonovo Inc, H1 2020

Stroke - Pipeline by Yantai YenePharma Co Ltd, H1 2020

Stroke - Pipeline by Zensun (Shanghai) Sci & Tech Co Ltd, H1 2020

Stroke - Pipeline by Zhejiang Ausun Pharmaceutical Co Ltd, H1 2020

Stroke - Pipeline by Zocere Inc, H1 2020

Stroke - Pipeline by ZyVersa Therapeutics Inc, H1 2020

Stroke - Pipeline by ZZ Biotech LLC, H1 2020

Stroke - Dormant Projects, H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..1), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..2), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..3), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..4), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..5), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..6), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..7), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..8), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..9), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..10), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..11), H1 2020

Stroke - Dormant Projects, H1 2020 (Contd..12), H1 2020

Stroke - Discontinued Products, H1 2020

Stroke - Discontinued Products, H1 2020 (Contd..1), H1 2020

Stroke - Discontinued Products, H1 2020 (Contd..2), H1 2020



List of Figures

Number of Products under Development for Stroke, H1 2020

Number of Products under Development by Companies, H1 2020

Number of Products under Development by Universities/Institutes, H1 2020

Number of Products by Top 10 Targets, H1 2020

Number of Products by Stage and Top 10 Targets, H1 2020

Number of Products by Top 10 Mechanism of Actions, H1 2020

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020

Number of Products by Top 10 Routes of Administration, H1 2020

Number of Products by Stage and Top 10 Routes of Administration, H1 2020

Number of Products by Top 10 Molecule Types, H1 2020

Number of Products by Stage and Top 10 Molecule Types, H1 2020
CHOOSE YOUR BUYING OPTION

NEED A HELP?

Submit your research need or query below

+91 9169162030 (Asia)
help@primemarketreports.com